LICENSING AGREEMENTS (Details Narrative) - USD ($)					12 Months Ended
	Dec. 27, 2013	Aug. 01, 2013	Feb. 24, 2010	Jul. 28, 2006	Dec. 31, 2016	Dec. 31, 2015	Apr. 18, 2011	Sep. 22, 2006
Viral Therapies Licensing Agreements [Member]
Maximum licensing payments				$ 10,000,000
Viral Therapies Licensing Agreements [Member] | Maximum [Member]
Milestone payment					$ 900,000
Viral Therapies Licensing Agreements [Member] | Officer [Member]
Rights to purchase shares of common stock				1,000,000
Exercise price of share purchase rights				$ 0.001
Influenza Vaccine Licensing Agreements [Member]
Payment to be made upon commencement								$ 70,000
Total licensing payments to be made								$ 283,420
Colby Pharmaceuticals Licensing Agreements [Member]
Shares issued for licensing agreements			294,118
Percentage to be paid from amount received under each agreement entered into before IND application is filed with the FDA					40.00%
Percentage to be paid from amount received under each agreement entered into after IND application until completion of a Phase I clinical trial					30.00%
Percentage to be paid from amount received under each agreement entered into from completion of a Phase I clinical trial through completion of a Phase II clinical trial					25.00%
Percentage to be paid from amount received under each agreement entered into from completion of a Phase II clinical trial until a NDA is approved by the FDA					20.00%
Percentage to be paid from amount received under each agreement entered into after the NDA has been approved by the FDA					10.00%
Colby Pharmaceuticals Licensing Agreements [Member] | Milestone I N D Filing [Member]
Milestone payment					$ 25,000
Colby Pharmaceuticals Licensing Agreements [Member] | Milestone First Patient Phase I I Trial [Member]
Milestone payment					150,000
Colby Pharmaceuticals Licensing Agreements [Member] | Milestone First Patient Phase I I I Trial [Member]
Milestone payment					200,000
Colby Pharmaceuticals Licensing Agreements [Member] | Milestone N D A Approval [Member]
Milestone payment					250,000
Colby Pharmaceuticals Licensing Agreements [Member] | Colby Pharmaceuticals [Member]
Shares issued for licensing agreements			47,059
Colby Pharmaceuticals Licensing Agreements [Member] | Related Party1 [Member]
Shares issued for licensing agreements			73,529
Colby Pharmaceuticals Licensing Agreements [Member] | Related Party2 [Member]
Shares issued for licensing agreements			73,529
Regents U C And Dana Farber Cancer Institute Licensing Agreements [Member]
License issue fee payable							$ 10,000
License maintenance fees payable on the first through third anniversary					10,000
License maintenance fees payable after the third anniversary through commercial sale of a product					$ 20,000
Earned royalty to be paid on net sales of licensed products					2.00%
License fees and reimbursed patent costs paid					$ 20,000	$ 20,000
Regents U C And Dana Farber Cancer Institute Licensing Agreements [Member] | Milestone Dosing 50 Percent Phase I Clinical Trial First [Member]
Milestone payment					25,000
Regents U C And Dana Farber Cancer Institute Licensing Agreements [Member] | Milestone I N D Filing Second [Member]
Milestone payment					25,000
Regents U C And Dana Farber Cancer Institute Licensing Agreements [Member] | Milestone Dosing First Patient Phase I I Clinical Trial First [Member]
Milestone payment					100,000
Regents U C And Dana Farber Cancer Institute Licensing Agreements [Member] | Milestone Dosing Fortieth Patient Phase I I Clinical Trial First [Member]
Milestone payment					150,000
Regents U C And Dana Farber Cancer Institute Licensing Agreements [Member] | Milestone Dosing First Patient Phase I I Clinical Trial Second [Member]
Milestone payment					250,000
Regents U C And Dana Farber Cancer Institute Licensing Agreements [Member] | Milestone Dosing First Patient Phase I I I Clinical Trial First [Member]
Milestone payment					600,000
Regents U C And Dana Farber Cancer Institute Licensing Agreements [Member] | Milestone Dosing First Patient Phase I I I Clinical Trial Second [Member]
Milestone payment					600,000
Regents U C And Dana Farber Cancer Institute Licensing Agreements [Member] | Milestone U S Regulatory Approval [Member]
Milestone payment					$ 1,000,000
Licensing Agreements 3M [Member]
Licensing agreement acquired	$ 7,000,000	$ 3,000,000
Patents & Taper DPI Intellectual Property [Member]
Discount rate	26.50%
WACC Premium	5.00%